274.19
price down icon0.52%   -1.42
after-market Dopo l'orario di chiusura: 271.80 -2.39 -0.87%
loading
Precedente Chiudi:
$275.61
Aprire:
$275.08
Volume 24 ore:
624.57K
Relative Volume:
0.64
Capitalizzazione di mercato:
$40.15B
Reddito:
$5.15B
Utile/perdita netta:
$1.40B
Rapporto P/E:
28.83
EPS:
9.51
Flusso di cassa netto:
$1.65B
1 W Prestazione:
+0.91%
1M Prestazione:
-6.65%
6M Prestazione:
+23.00%
1 anno Prestazione:
+10.94%
Intervallo 1D:
Value
$273.11
$277.43
Intervallo di 1 settimana:
Value
$270.49
$277.43
Portata 52W:
Value
$199.92
$293.81

Resmed Inc Stock (RMD) Company Profile

Name
Nome
Resmed Inc
Name
Telefono
(858) 746-2400
Name
Indirizzo
9001 SPECTRUM CENTER BLVD., SAN DIEGO, CA
Name
Dipendente
10,600
Name
Cinguettio
@resmed
Name
Prossima data di guadagno
2024-10-24
Name
Ultimi documenti SEC
Name
RMD's Discussions on Twitter

Confronta RMD con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Medical Instruments & Supplies icon
RMD
Resmed Inc
274.19 40.35B 5.15B 1.40B 1.65B 9.51
Medical Instruments & Supplies icon
ISRG
Intuitive Surgical Inc
443.99 160.51B 9.15B 2.63B 1.99B 7.17
Medical Instruments & Supplies icon
BDX
Becton Dickinson Co
186.05 53.46B 21.39B 1.61B 2.55B 5.56
Medical Instruments & Supplies icon
ALC
Alcon Inc
75.00 37.18B 10.03B 1.07B 1.39B 2.17
Medical Instruments & Supplies icon
WST
West Pharmaceutical Services Inc
259.94 18.03B 2.96B 487.70M 344.00M 6.68

Resmed Inc Stock (RMD) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-09-18 Iniziato Citigroup Buy
2025-09-02 Aggiornamento CLSA Hold → Outperform
2025-07-15 Aggiornamento RBC Capital Mkts Sector Perform → Outperform
2025-03-19 Iniziato Morgan Stanley Overweight
2025-01-16 Iniziato Goldman Buy
2025-01-10 Iniziato Piper Sandler Neutral
2024-12-13 Iniziato Stifel Hold
2024-09-24 Iniziato Robert W. Baird Outperform
2024-09-18 Downgrade Wolfe Research Peer Perform → Underperform
2024-09-04 Downgrade Needham Buy → Hold
2024-06-25 Downgrade Oppenheimer Outperform → Perform
2024-06-24 Downgrade Citigroup Buy → Neutral
2024-02-06 Ripresa KeyBanc Capital Markets Overweight
2023-10-27 Aggiornamento Morgan Stanley Equal-Weight → Overweight
2023-10-12 Downgrade RBC Capital Mkts Outperform → Sector Perform
2023-10-09 Aggiornamento JP Morgan Neutral → Overweight
2023-09-29 Downgrade Wolfe Research Outperform → Peer Perform
2023-09-06 Aggiornamento Needham Hold → Buy
2023-09-05 Downgrade UBS Buy → Neutral
2023-08-01 Aggiornamento RBC Capital Mkts Sector Perform → Outperform
2023-05-23 Iniziato UBS Buy
2023-04-14 Iniziato Mizuho Buy
2023-01-17 Aggiornamento JP Morgan Neutral → Overweight
2022-10-28 Downgrade Citigroup Buy → Neutral
2022-10-20 Aggiornamento BofA Securities Neutral → Buy
2022-10-12 Iniziato Jefferies Hold
2022-09-08 Aggiornamento Citigroup Neutral → Buy
2022-08-15 Downgrade CLSA Buy → Outperform
2022-08-12 Downgrade Citigroup Buy → Neutral
2022-08-12 Downgrade JP Morgan Overweight → Neutral
2022-08-12 Downgrade RBC Capital Mkts Outperform → Sector Perform
2022-06-06 Aggiornamento RBC Capital Mkts Sector Perform → Outperform
2022-04-06 Iniziato Wolfe Research Outperform
2022-01-31 Aggiornamento Citigroup Neutral → Buy
2022-01-31 Aggiornamento Goldman Neutral → Buy
2022-01-28 Aggiornamento RBC Capital Mkts Underperform → Sector Perform
2022-01-24 Aggiornamento BofA Securities Underperform → Neutral
2022-01-24 Aggiornamento JP Morgan Neutral → Overweight
2022-01-13 Aggiornamento CLSA Outperform → Buy
2022-01-13 Aggiornamento Robert W. Baird Neutral → Outperform
2021-12-21 Aggiornamento KeyBanc Capital Markets Sector Weight → Overweight
2021-12-06 Aggiornamento Macquarie Neutral → Outperform
2021-10-22 Aggiornamento CLSA Underperform → Outperform
2021-08-02 Downgrade CLSA Outperform → Sell
2021-08-02 Downgrade Needham Buy → Hold
2021-07-28 Aggiornamento Jefferies Underperform → Hold
2021-07-26 Downgrade JP Morgan Overweight → Neutral
2021-07-14 Iniziato RBC Capital Mkts Underperform
2021-06-28 Downgrade Citigroup Buy → Neutral
2021-06-22 Aggiornamento Macquarie Neutral → Outperform
2021-06-22 Iniziato Robert W. Baird Neutral
2021-06-21 Reiterato Needham Buy
2021-06-16 Downgrade BofA Securities Neutral → Underperform
2021-06-09 Aggiornamento CLSA Sell → Outperform
2021-05-21 Aggiornamento JP Morgan Neutral → Overweight
2021-05-11 Aggiornamento Citigroup Neutral → Buy
2021-04-30 Downgrade Citigroup Buy → Neutral
2021-03-16 Aggiornamento Needham Hold → Buy
2020-11-02 Aggiornamento UBS Neutral → Buy
2020-10-30 Aggiornamento JP Morgan Underweight → Neutral
2020-10-27 Aggiornamento BofA Securities Underperform → Neutral
2020-08-07 Downgrade Morgan Stanley Overweight → Equal-Weight
2020-06-17 Aggiornamento Morgan Stanley Equal-Weight → Overweight
2020-05-01 Downgrade JP Morgan Neutral → Underweight
2020-05-01 Aggiornamento Oppenheimer Perform → Outperform
2020-02-18 Downgrade Morgan Stanley Overweight → Equal-Weight
2020-02-03 Iniziato CLSA Underperform
2020-01-31 Downgrade UBS Buy → Neutral
2020-01-10 Iniziato Oppenheimer Perform
2019-11-22 Iniziato KeyBanc Capital Markets Sector Weight
2019-07-29 Aggiornamento UBS Neutral → Buy
2019-07-16 Downgrade UBS Buy → Neutral
2019-05-06 Aggiornamento UBS Neutral → Buy
2019-04-18 Aggiornamento JP Morgan Underweight → Neutral
2019-01-25 Downgrade Goldman Buy → Neutral
2019-01-25 Downgrade JP Morgan Neutral → Underweight
2018-10-26 Aggiornamento Credit Suisse Neutral → Outperform
2018-07-02 Iniziato Goldman Buy
Mostra tutto

Resmed Inc Borsa (RMD) Ultime notizie

pulisher
Sep 24, 2025

ResMed's (NYSE:RMD) investors will be pleased with their respectable 66% return over the last five years - Yahoo Finance

Sep 24, 2025
pulisher
Sep 24, 2025

BDF Gestion Sells 1,159 Shares of ResMed Inc. $RMD - MarketBeat

Sep 24, 2025
pulisher
Sep 24, 2025

Yarbrough Capital LLC Grows Stake in ResMed Inc. $RMD - MarketBeat

Sep 24, 2025
pulisher
Sep 24, 2025

ResMed Inc. $RMD Shares Purchased by IFM Investors Pty Ltd - MarketBeat

Sep 24, 2025
pulisher
Sep 24, 2025

Assenagon Asset Management S.A. Purchases 28,801 Shares of ResMed Inc. $RMD - MarketBeat

Sep 24, 2025
pulisher
Sep 23, 2025

ResMed targets 59-60% gross margins and expanded global reach for AirSense 11 - MSN

Sep 23, 2025
pulisher
Sep 23, 2025

Transcript : ResMed Inc. Presents at Bank of America Global Healthcare Conference 2025, Sep-23-2025 12 - MarketScreener

Sep 23, 2025
pulisher
Sep 23, 2025

ResMed (NYSE:RMD) Coverage Initiated by Analysts at Citigroup - MarketBeat

Sep 23, 2025
pulisher
Sep 23, 2025

Swedbank AB Increases Stake in ResMed Inc. $RMD - MarketBeat

Sep 23, 2025
pulisher
Sep 23, 2025

Mn Services Vermogensbeheer B.V. Acquires 1,700 Shares of ResMed Inc. $RMD - MarketBeat

Sep 23, 2025
pulisher
Sep 22, 2025

Marshall Financial Group LLC Trims Position in ResMed Inc. $RMD - MarketBeat

Sep 22, 2025
pulisher
Sep 22, 2025

Brendan Caldwell's Past Picks: ResMed, Carrier Global Corp & Equifax - BNN Bloomberg

Sep 22, 2025
pulisher
Sep 22, 2025

Caitlin John LLC Has $1.45 Million Holdings in ResMed Inc. $RMD - MarketBeat

Sep 22, 2025
pulisher
Sep 22, 2025

Pallas Capital Advisors LLC Sells 1,924 Shares of ResMed Inc. $RMD - MarketBeat

Sep 22, 2025
pulisher
Sep 22, 2025

Primer: ResMed Inc (RMD AU)Sep 2025 - Smartkarma

Sep 22, 2025
pulisher
Sep 22, 2025

Financiere des Professionnels Fonds d investissement inc. Invests $419,000 in ResMed Inc. $RMD - MarketBeat

Sep 22, 2025
pulisher
Sep 22, 2025

Czech National Bank Raises Position in ResMed Inc. $RMD - MarketBeat

Sep 22, 2025

Resmed Inc Azioni (RMD) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
medical_instruments_supplies ALC
$75.00
price down icon 0.27%
medical_instruments_supplies BDX
$186.05
price down icon 0.25%
medical_instruments_supplies WST
$259.94
price up icon 3.64%
$66.40
price down icon 1.83%
medical_instruments_supplies COO
$68.35
price up icon 1.26%
Capitalizzazione:     |  Volume (24 ore):